Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Bill Taaffe
AddedMar 31, 2024
UpdatedMay 31, 2026
Bill Taaffe

Bill Taaffe

Board Member, Strategikon Pharma

CrunchbaseLinkedIn

Bill Taaffe's Career

Strategikon Pharma
Strategikon Pharma

San Rafael, CA, US

Board Member· Board
Insight Genetics
Insight Genetics

Nashville, TN, US

Board Member· Board
Spencer Health Solutions
Spencer Health Solutions

Morrisville, NC, US

Board Member· Board
ObjectiveHealth
ObjectiveHealth

Franklin, TN, US

Board Member· Board
ObvioHealth
ObvioHealth

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Bill Taaffe's Career

Strategikon Pharma
Strategikon Pharma
Angel$25k272017San Rafael, CA, US
Board Member· Board

Leadership at Strategikon Pharma

Paulo CarvalhoPaulo CarvalhoCo-Founder
Ineke RijnhoutIneke RijnhoutBoard Member
Anca CopaescuAnca CopaescuCo-Founder
Mark DiianniMark DiianniBoard Member
Insight Genetics
Insight Genetics
Acquired$4.5M02005Nashville, TN, US
Board Member· Board

Leadership at Insight Genetics

Stephan MorrisStephan MorrisFounder
Eric DahlhauserEric DahlhauserBoard Member

Similar to Insight Genetics

InnSight TechnologyInnSight TechnologyPittsburgh, PA, USBiosensors, Diagnosticsest. 2014InnSight TechnologyPittsburgh, PA, US · est. 2014

InnSight Technology: Advancing eye disease diagnostics through innovative biotechnology.

Pre-Seed · $1.3M11
Genome InsightGenome InsightSan Diego, CA, USGenome Sequencingest. 2020Genome InsightSan Diego, CA, US · est. 2020

Genome Insight: Expert in whole genome sequence analysis and interpretation.

Series B · $52.7M57
InvitaeInvitaeSan Francisco, CA, USGenetic Testingest. 2010InvitaeSan Francisco, CA, US · est. 2010

Invitae Corp., a global genetic information company, specializes in diagnostics, oncology, pediatrics, and hereditary screening.

Public · $2.5B1.7k
Myriad GeneticsMyriad GeneticsSalt Lake City, UT, USDiagnostic Productsest. 1991Myriad GeneticsSalt Lake City, UT, US · est. 1991

American biotech firm, Myriad Genetics, Inc., develops and markets diagnostic products for early disease detection and prevention.

Public · $90M2.6k
Spencer Health Solutions
Spencer Health Solutions
Series D$66.5M902015Morrisville, NC, US
Board Member· Board

Leadership at Spencer Health Solutions

Thomas RhoadsThomas RhoadsFounder
Mark GilreathMark GilreathBoard Member
ObjectiveHealth
ObjectiveHealth
Private Equity$13.6M1452018Franklin, TN, US
Board Member· Board

Leadership at ObjectiveHealth

Don LazasDon LazasCo-Founder
Colleen HokeColleen HokeBoard Member
ObvioHealth
ObvioHealth
Series B$61.9M1722017New York City, NY, US
Board Member· Board

Leadership at ObvioHealth

Ivan JarryIvan JarryCEO

Similar to ObvioHealth

ClinOneClinOneNeedham, MA, USClinical Trialsest. 2016ClinOneNeedham, MA, US · est. 2016

ClinOne: Streamlining clinical trials with web and mobile solutions for improved patient experience.

Series A · $10.5M75
MedableMedablePalo Alto, CA, USClinical Researchest. 2015MedablePalo Alto, CA, US · est. 2015

Medable: Accelerating therapies with a global cloud platform for efficient clinical research.

Series D · $506.6M750
CurebaseCurebaseSan Francisco, CA, USClinical Trials Softwareest. 2017CurebaseSan Francisco, CA, US · est. 2017

Curebase: Revolutionizing clinical trials with digital, accessible at-home research tools.

Series B · $57.5M175
Faro HealthFaro HealthSan Diego, CA, USClinical Trials Softwareest. 2019Faro HealthSan Diego, CA, US · est. 2019

Faro Health: Streamlining clinical trials with our cloud-native platform.

Series A · $35M42

Bill Taaffe's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Bill Taaffe

Joe EwartJoe EwartBoard Member · Advanced AVWill HarbinWill HarbinBoard Member · Cendana CapitalMark CrandallMark CrandallBoard Member · PostScriptum VenturesBreht FeighBreht FeighBoard Member · Schweiger DermatologyHank HabichtHank HabichtBoard Member · Water Health InternationalMaurizio VecchioneMaurizio VecchioneFounder · AdAstral Funds